This is unpublished

Edus Houston
Warren
M.D.
Ph.D.

Edus Houston Warren

(206) 667-6441

Fred Hutchinson Cancer Center 

1100 Fairview Ave. N, S3-204 

Seattle, WA 98109-1024 

Physician & Research Faculty
Pinned
Academic
Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center
Professor, Vaccine and Infectious Disease Division, Fred Hutch
Program Head, Global Oncology, Fred Hutch
Professor, Division of Hematology and Oncology, University of Washington
Adjunct Professor, Department of Laboratory Medicine and Pathology, UW
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union
Fred Hutchinson Cancer Center at UW Medical Center – Montlake

Photo: Fred Hutch

Education, Training, Board Certifications

  • Ph.D., Harvard University 
  • M.D., Harvard Medical School 
  • Internship and Residency in Internal Medicine, Massachusetts General Hospital 
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine 

Clinical Expertise 

  • Hematologic malignancies/lymphoma 
  • Immunotherapy 
  • Global oncology 

Affiliations 

Publications

PubMed

Research and/or clinical interests

Dr. Edus ("Hootie") H. Warren is an oncologist who focuses on the care of patients with lymphoma as well as a scientist whose laboratory studies how the power of the immune system can be harnessed to treat and eliminate cancer. Dr. Warren contributed to the development of adoptive T-cell therapy for leukemia and, in collaboration with several colleagues from Fred Hutch, co-developed a method for profiling the millions of T- and B-lymphocytes that comprise the adaptive arm of the immune system. His laboratory is actively studying how to exploit the power of the immune system to treat lymphoma and kidney cancer. Since 2017 Dr. Warren has also served as the head of the Global Oncology (GO) Program at Fred Hutch, whose mission is to eliminate cancer and related diseases as causes of human suffering and death through prevention and curative treatments accessible to all patients. The GO Program operates a 25,000 ft2 cancer research center located in Kampala, Uganda on the campus of the Uganda Cancer Institute (UCI). In collaboration with the UCI, the Fred Hutch GO Program conducts research on the prevention, diagnosis, and treatment of cancers that are common in sub-Saharan Africa, many of which are caused by infectious agents such as viruses and bacteria. These infection-related cancers include lymphoma associated with Epstein-Barr virus (EBV), sarcomas associated with human herpesvirus 8 (HHV-8), cervical cancer associated with human papillomavirus (HPV), and liver cancer associated with hepatitis B and hepatitis C viruses (HBV and HCV).